ClinicalTrials.gov
public full text
Public Domain
Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service
This study aims to evaluate the impact of AbbVie Care 2.0 on adalimumab's compliance, patient reported outcomes and utilization of health resources over 12 months.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Employment and Arthritis: Making it Work#839147
- A Comparison of Two Different Methods of Physical Therapy to Treat Acute and Subacute Low Back Pain#850058
- The PIP-STOPP Study#879155
- A Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Subjects With Crohn's Disease#867042
- TRANSCEND-T2D-1 and the First-Line Question: What Retatrutide's Phase 3 Results Mean for Diabetes Care, Access & Equity#302262
Record · ID 841776
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive